ArticleBreast cancer research : BCR2008

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity.

Sacha J Howell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.